A phase 2 non-randomized clinical trial tested the diagnostic potential of CAIX-PET, an experimental imaging modality, to detect VHL-related clear cell renal cell carcinoma and other VHL-associated ...

Metastatic kidney survival rates don’t predict individual outcomes. A number of factors, including overall health, tumor characteristics, and response to treatment, influence prognosis and survival.

Naomi Haas, MD, from the Hospital at the University of Pennsylvania, explains that most trials regarding neoadjuvant therapy ...

In an interview with Targeted Oncology, Pavlos Msaouel, MD, PhD, at The University of Texas MD Anderson Cancer Center ...

Data build on findings presented at ESMO 2025 and support potential of darlifarnib to overcome resistance and resensitize tumors to VEGFR TKI ...

Immunotherapy and targeted therapy are often the first lines of treatment for advanced kidney cancer, with surgery and radiation also possible.

A cancer-causing chemical that is widely used to degrease aviation components and heavy machinery could also be linked to Parkinson's disease, according to a new research paper that recommends ...

The advanced renal cell carcinoma (RCC) treatment market has demonstrated significant growth, with projections indicating an ...

HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Nephrologists routinely use biopsy of the kidney for making diagnoses ...

The renal cell carcinoma market has shown consistent growth, moving from $4.96 billion in 2025 to an expected $5.13 billion ...